ERBB3 and neoplasm: After finding that HER3-specific antibodies inhibited HER3+ tumor cell proliferation in vitro, we sought to demonstrate the effects of HER3-VIA in vivo against the metastatic human xenograft model BT474M1 that expresses both HER2 and HER3 (Fig. 4a).